Yutao Yan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yutao Yan has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Didier Merlin
Department of Medicine, Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA, USA
16 shared publications Shanthi V. Sitaraman
16 shared publications- Guillaume Dalmasso
M2iSH, UMR 1071 Inserm, Université Clermont Auvergne, INRAE USC 2018, CRNH, 63001 Clermont-Ferrand, France
13 shared publications - Hamed Laroui
Department of Medicine, Division of Digestive Diseases, Emory University, Atlanta, Georgia 30322, USA
11 shared publications - Hang Thi Thu Nguyen9 shared publications
- Moiz A. Charania
Department of Biology, Center Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia, USA
9 shared publications
Latest Publications
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Tu1845 Intestinal Epithelial CD98 Plays a Role in the Host Defense Response to Intestinal Inflammation
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Tu1845 Intestinal Epithelial CD98 Plays a Role in the Host Defense Response to Intestinal Inflammation
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo1736 Knockdown of STE20-Like Proline/Alanine-Rich Kinase (SPAK) Attenuates Intestinal Inflammation in Mouse
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo1736 Knockdown of STE20-Like Proline/Alanine-Rich Kinase (SPAK) Attenuates Intestinal Inflammation in Mouse
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Sa1850 Designing Targeted F4/80-Coated TNFA SiRNA-Loaded Nanoparticles: A Novel Therapeutic Approach to Treat IBD
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Sa1850 Designing Targeted F4/80-Coated TNFA SiRNA-Loaded Nanoparticles: A Novel Therapeutic Approach to Treat IBD
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo2041 A2BAR Exacerbates Intestinal Inflammation
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo2041 A2BAR Exacerbates Intestinal Inflammation
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo1594 The Role Played by PepT1 in Colitis-Associated Cancer
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo1594 The Role Played by PepT1 in Colitis-Associated Cancer
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo2016 Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes With Medium-Chain-Length Fatty Acids in the Colon
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo2016 Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes With Medium-Chain-Length Fatty Acids in the Colon
- 1 August 2011
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 187 (3) , 1496-1505
Overexpression of Ste20-Related Proline/Alanine-Rich Kinase Exacerbates Experimental Colitis in Mice
Inflammatory bowel disease, mainly Crohn’s disease and ulcerative colitis, are characterized by epithelial barrier disruption and altered immune regulation. Colonic Ste20-like proline/alanine-rich kinase (SPAK) plays a role in intestinal inflammation, but its underlying mechanisms need to be defined. Both SPAK-transfected Caco2-BBE cells and villin-SPAK transgenic (TG) FVB/6 mice exhibited loss of intestinal barrier function. Further studies demonstrated that SPAK significantly increased paracellular intestinal permeability to FITC-dextran. In vivo studies using the mouse models of colitis induced by dextran sulfate sodium (DSS) and trinitrobenzene sulfonic acid showed that TG FVB/6 mice were more susceptible to DSS and trinitrobenzene sulfonic acid treatment than wild-type FVB/6 mice, as demonstrated by clinical and histological characteristics and enzymatic activities. Consistent with this notion, we found that SPAK increased intestinal epithelial permeability, which likely facilitated the production of inflammatory cytokines in vitro and in vivo, aggravated bacterial translocation in TG mice under DSS treatment, and consequently established a context favorable for the triggering of intestinal inflammation cascades. In conclusion, overexpression of SPAK inhibits maintenance of intestinal mucosal innate immune homeostasis, which makes regulation of SPAK important to attenuate pathological responses in inflammatory bowel disease.
- 1 August 2011
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 187 (3) , 1496-1505
Overexpression of Ste20-Related Proline/Alanine-Rich Kinase Exacerbates Experimental Colitis in Mice
Inflammatory bowel disease, mainly Crohn’s disease and ulcerative colitis, are characterized by epithelial barrier disruption and altered immune regulation. Colonic Ste20-like proline/alanine-rich kinase (SPAK) plays a role in intestinal inflammation, but its underlying mechanisms need to be defined. Both SPAK-transfected Caco2-BBE cells and villin-SPAK transgenic (TG) FVB/6 mice exhibited loss of intestinal barrier function. Further studies demonstrated that SPAK significantly increased paracellular intestinal permeability to FITC-dextran. In vivo studies using the mouse models of colitis induced by dextran sulfate sodium (DSS) and trinitrobenzene sulfonic acid showed that TG FVB/6 mice were more susceptible to DSS and trinitrobenzene sulfonic acid treatment than wild-type FVB/6 mice, as demonstrated by clinical and histological characteristics and enzymatic activities. Consistent with this notion, we found that SPAK increased intestinal epithelial permeability, which likely facilitated the production of inflammatory cytokines in vitro and in vivo, aggravated bacterial translocation in TG mice under DSS treatment, and consequently established a context favorable for the triggering of intestinal inflammation cascades. In conclusion, overexpression of SPAK inhibits maintenance of intestinal mucosal innate immune homeostasis, which makes regulation of SPAK important to attenuate pathological responses in inflammatory bowel disease.
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Overexpression of PepT1 Increases the Susceptibility of Mice to Colitis in a Process Involving NOD2 Activity
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Overexpression of PepT1 Increases the Susceptibility of Mice to Colitis in a Process Involving NOD2 Activity
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Tri-Dap Interacts Directly With the Lrr Domain of NOD1 and Consequently Regulates Rick/NOD1 Interactions
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Tri-Dap Interacts Directly With the Lrr Domain of NOD1 and Consequently Regulates Rick/NOD1 Interactions
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Silencing of CD98 Expression Using a Nanoparticle-Based Delivery System Ameliorates Induced Colitis in Mice
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Silencing of CD98 Expression Using a Nanoparticle-Based Delivery System Ameliorates Induced Colitis in Mice